open access

Vol 12, No 3 (2006)
Original papers
Published online: 2006-08-01
Get Citation

Pleiotropic effects of simvastatin in patients with peripheral arterial occlusive disease

Krzysztof Bieroń, Lilia Grodzińska, Dorota Starzyk, Aleksandra Goszcz, Magdalena Łomnicka, Ryszard Korbut
Acta Angiologica 2006;12(3):85-96.

open access

Vol 12, No 3 (2006)
Original papers
Published online: 2006-08-01

Abstract

Background. Simvastatin has a consolidated position in the primary and secondary prevention of cardiovascular disease in high risk patients. Simvastatin, independently of its hypolipaemic action, changes endothelial function, stabilises atheromatous plaques and exerts antithrombotic and anti-inflammatory action. The purpose of this paper was to verify the pleiotropic action of simvastatin in PAOD patients with normo- and hypercholesterolaemia.
Material and methods. Twenty patients with peripheral aterial occlusive disease (PAOD): 10 normocholesterolaemic (NCH) and 10 hypercholesterolaemic (HCH), 41-75 years, old were included in the study. The patients were treated with 40 mg of simvastatin daily for 3 months. At the beginning of the therapy, after one month and three months of treatment lipid levels and clinical investigations were performed. Laboratory estimations were determined before starting therapy and 3 hours after ingestion of simvastatin tablets. The same procedure was repeated after one month and three months of therapy, always 12 hours after the last dose and 3 hours after intake of the tablet.
Results. Simvastatin caused significant reduction of TC, LDL and TG levels in both study groups. No changes in HDL levels were observed. An increase of ABI and FMD in the NCH group were observed. A significant increase of FMD, of pain-free and total walking distances were seen In HCH patients; no changes in ABI were observed. In both study groups significant fibrinolytic and antiplatelet action were observed, more distinct in the HCH group. No changes in the levels of t-PA antigen, RBC deformability and aggregability were seen in both study groups.
Conclusions. Simvastatin therapy caused clinical improvement in PAOD patients independently of its lipid lowering properties. These beneficial simvastatin effects may be related to the pleiotropic action and restoration of endothelial function.

Abstract

Background. Simvastatin has a consolidated position in the primary and secondary prevention of cardiovascular disease in high risk patients. Simvastatin, independently of its hypolipaemic action, changes endothelial function, stabilises atheromatous plaques and exerts antithrombotic and anti-inflammatory action. The purpose of this paper was to verify the pleiotropic action of simvastatin in PAOD patients with normo- and hypercholesterolaemia.
Material and methods. Twenty patients with peripheral aterial occlusive disease (PAOD): 10 normocholesterolaemic (NCH) and 10 hypercholesterolaemic (HCH), 41-75 years, old were included in the study. The patients were treated with 40 mg of simvastatin daily for 3 months. At the beginning of the therapy, after one month and three months of treatment lipid levels and clinical investigations were performed. Laboratory estimations were determined before starting therapy and 3 hours after ingestion of simvastatin tablets. The same procedure was repeated after one month and three months of therapy, always 12 hours after the last dose and 3 hours after intake of the tablet.
Results. Simvastatin caused significant reduction of TC, LDL and TG levels in both study groups. No changes in HDL levels were observed. An increase of ABI and FMD in the NCH group were observed. A significant increase of FMD, of pain-free and total walking distances were seen In HCH patients; no changes in ABI were observed. In both study groups significant fibrinolytic and antiplatelet action were observed, more distinct in the HCH group. No changes in the levels of t-PA antigen, RBC deformability and aggregability were seen in both study groups.
Conclusions. Simvastatin therapy caused clinical improvement in PAOD patients independently of its lipid lowering properties. These beneficial simvastatin effects may be related to the pleiotropic action and restoration of endothelial function.
Get Citation

Keywords

simvastatin; peripheral arterial occlusive disease; hypolipaemic and pleiotropic action

About this article
Title

Pleiotropic effects of simvastatin in patients with peripheral arterial occlusive disease

Journal

Acta Angiologica

Issue

Vol 12, No 3 (2006)

Pages

85-96

Published online

2006-08-01

Bibliographic record

Acta Angiologica 2006;12(3):85-96.

Keywords

simvastatin
peripheral arterial occlusive disease
hypolipaemic and pleiotropic action

Authors

Krzysztof Bieroń
Lilia Grodzińska
Dorota Starzyk
Aleksandra Goszcz
Magdalena Łomnicka
Ryszard Korbut

Important: This website uses cookies.tanya dokter More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl